Samuel C. Blackman, HEAD OF RESEARCH AND DEVELOPME at Day One Biopharmaceuticals, Inc. (DAWN), sold 2,258 shares at $15.25 ($34K) on 2024-02-16, disclosed to the SEC on 2024-02-20.
Open-market sale of $34k DAWN by HEAD OF RESEARCH AND DEVELOPME. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2024-11-12 | $751K | — | Filing → |
| DAWN | SELL | 2024-11-08 | $361K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |